| Name | Title | Contact Details |
|---|
Bp Solvay Polyethylene is a Houston, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders. Ganaxolone is a positive allosteric modulator of GABAA receptors that acts on a well-characterized target in the brain known to have anti-seizure, anti-depressant, and anti-anxiety effects. Ganaxolone is being developed in IV and oral dose forms intended to maximize therapeutic reach to adult and pediatric patient populations in both acute and chronic care settings. Marinus is conducting the first ever Phase 3 pivotal trial in children with CDKL5 deficiency disorder, along with a Phase 2 trial in Tuberous Sclerosis Complex, and a Phase 2 biomarker driven proof of concept trial in PCDH19-related epilepsy.
Michigan Life Science Network is a Kalamazoo, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Wyandot BHN is a family of organizations providing comprehensive behavioral health solutions to Wyandotte County, Kansas and the greater Kansas City metro.
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients` diseased blood and immune system with a healthy one.